Oncogenic structural aberration landscape in gastric cancer genomes.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
22 06 2023
Historique:
received: 09 03 2022
accepted: 05 06 2023
medline: 26 6 2023
pubmed: 23 6 2023
entrez: 22 6 2023
Statut: epublish

Résumé

Structural variants (SVs) are responsible for driver events in gastric cancer (GC); however, their patterns and processes remain poorly understood. Here, we examine 170 GC whole genomes to unravel the oncogenic structural aberration landscape in GC genomes and identify six rearrangement signatures (RSs). Non-random combinations of RSs elucidate distinctive GC subtypes comprising one or a few dominant RS that are associated with specific driver events (BRCA1/2 defects, mismatch repair deficiency, and TP53 mutation) and epidemiological backgrounds. Twenty-seven SV hotspots are identified as GC driver candidates. SV hotspots frequently constitute complexly clustered SVs involved in driver gene amplification, such as ERBB2, CCNE1, and FGFR2. Further deconstruction of the locally clustered SVs uncovers amplicon-generating profiles characterized by super-large SVs and intensive segmental amplifications, contributing to the extensive amplification of GC oncogenes. Comprehensive analyses using adjusted SV allele frequencies indicate the significant involvement of extra-chromosomal DNA in processes linked to specific RSs.

Identifiants

pubmed: 37349325
doi: 10.1038/s41467-023-39263-1
pii: 10.1038/s41467-023-39263-1
pmc: PMC10287692
doi:

Substances chimiques

BRCA1 protein, human 0
BRCA1 Protein 0
BRCA2 protein, human 0
BRCA2 Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3688

Informations de copyright

© 2023. The Author(s).

Références

Nature. 2020 Feb;578(7793):112-121
pubmed: 32025012
Nat Commun. 2017 Nov 3;8(1):1315
pubmed: 29101368
Nat Genet. 2022 Feb;54(2):107-114
pubmed: 35145302
Cancer Discov. 2018 Jan;8(1):108-125
pubmed: 28963353
Nat Genet. 2020 Sep;52(9):958-968
pubmed: 32747826
Nature. 2014 Sep 11;513(7517):202-9
pubmed: 25079317
Cold Spring Harb Perspect Biol. 2015 Feb 02;7(2):a016592
pubmed: 25646380
Nat Commun. 2014 Jul 10;5:4361
pubmed: 25008978
Genome Res. 2014 Sep;24(9):1411-20
pubmed: 25024164
Nat Commun. 2019 Jan 23;10(1):392
pubmed: 30674876
Nat Genet. 2020 Sep;52(9):891-897
pubmed: 32807987
Nat Genet. 2017 Dec;49(12):1779-1784
pubmed: 29083409
Nature. 2016 May 23;534(7607):402-6
pubmed: 27281199
Nat Commun. 2019 May 2;10(1):2037
pubmed: 31048690
Nature. 2010 Oct 28;467(7319):1109-13
pubmed: 20981101
Nat Genet. 2015 Sep;47(9):1003-10
pubmed: 26258846
Nucleic Acids Res. 2016 Sep 19;44(16):e131
pubmed: 27270079
BMC Genomics. 2019 Apr 18;19(Suppl 9):985
pubmed: 30999860
Genome Biol. 2015 Apr 08;16:72
pubmed: 25886137
Trends Genet. 2022 Jul;38(7):766-781
pubmed: 35277298
Nat Genet. 2018 Aug;50(8):1189-1195
pubmed: 30013179
Bioinformatics. 2022 Jun 27;38(13):3470-3473
pubmed: 35595234
World J Gastroenterol. 2014 Oct 14;20(38):13741-55
pubmed: 25320512
Nat Genet. 2020 Apr;52(4):464
pubmed: 32107479
Bioinformatics. 2010 Jun 15;26(12):1572-3
pubmed: 20427518
Commun Biol. 2022 Apr 8;5(1):335
pubmed: 35396535
Oncogene. 2003 Jan 16;22(2):281-90
pubmed: 12527897
Nat Cancer. 2020 Feb;1(2):249-263
pubmed: 32118208
Nature. 2016 May 02;534(7605):47-54
pubmed: 27135926
Pathogenetics. 2008 Nov 03;1(1):4
pubmed: 19014668
Cell. 2013 Nov 7;155(4):934-47
pubmed: 24119843
Cell. 2020 Oct 1;183(1):197-210.e32
pubmed: 33007263
Genome Res. 2018 Aug;28(8):1126-1135
pubmed: 29954844
Mob DNA. 2015 Dec 29;6:24
pubmed: 26719777
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Cancer Discov. 2022 Mar 1;12(3):692-711
pubmed: 34880079
Nat Rev Cancer. 2017 Jul 25;17(8):489-501
pubmed: 28740117
Blood. 2017 Apr 27;129(17):2347-2358
pubmed: 28223278
Oncol Rep. 2006 Mar;15(3):595-601
pubmed: 16465418
Biostatistics. 2004 Oct;5(4):557-72
pubmed: 15475419
Cell. 2014 Nov 20;159(5):1110-1125
pubmed: 25416949
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nature. 2017 Mar 2;543(7643):122-125
pubmed: 28178237
Cell Rep. 2015 Jul 14;12(2):272-85
pubmed: 26146084
Bioinformatics. 2015 Jan 1;31(1):116-8
pubmed: 25192740
Nat Genet. 2023 Apr;55(4):581-594
pubmed: 36914835
Nature. 2022 Feb;602(7897):510-517
pubmed: 35140399
Nat Genet. 2014 Jun;46(6):573-82
pubmed: 24816253
Cell. 2017 Jul 27;170(3):564-576.e16
pubmed: 28753430
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nat Genet. 2021 Dec;53(12):1673-1685
pubmed: 34782764
Cancer Res. 2001 May 15;61(10):4238-43
pubmed: 11358850
Science. 2014 Aug 01;345(6196):1251343
pubmed: 25082706
Genome Biol. 2016 Feb 22;17:31
pubmed: 26899170
Nature. 2015 Jun 11;522(7555):179-84
pubmed: 26017310

Auteurs

Mihoko Saito-Adachi (M)

Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.

Natsuko Hama (N)

Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.

Yasushi Totoki (Y)

Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Department of Cancer Genome Informatics, Graduate School of Medicine, Osaka University, Osaka, Japan.

Hiromi Nakamura (H)

Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.

Yasuhito Arai (Y)

Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.

Fumie Hosoda (F)

Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.

Hirofumi Rokutan (H)

Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Shinichi Yachida (S)

Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Department of Cancer Genome Informatics, Graduate School of Medicine, Osaka University, Osaka, Japan.

Mamoru Kato (M)

Division of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan.

Akihiko Fukagawa (A)

Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.

Tatsuhiro Shibata (T)

Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan. tashibat@ncc.go.jp.
Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. tashibat@ncc.go.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH